Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by CarbonWarrioron Nov 22, 2022 10:53pm
231 Views
Post# 35120734

RE:RE:RE:RE:Advanced Pancreatic Cancer Trial - NU 18I01

RE:RE:RE:RE:Advanced Pancreatic Cancer Trial - NU 18I01 Wow the bitterness here is intense. Hope is gone. Now the time to buy buy buy like crazy.

Look, drowning in your sorrows isn't going to make SP go up.

The bottom line is that this company had a very advance product for its time (a virus). They did not know how to harness it. Took forever and now they have 3 or even 4 shot at it

-Pancreatic
-Breast cancer
-Skin (yes this one might pop back)
-CAR T

Other virus/oncology winner is advancing the science. The timing is now to get in.
SP will go up soon as we get closer to Dec 7th and higher as we got closer and closer to Bracelet data day.
I am exiting at 6$ 
Ride with me or also ride against me. C'mon short this baby dow. 'cause I am adding like crazy and will squeeze your short.




<< Previous
Bullboard Posts
Next >>